Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,064 | 309 | 98.6% |
| Education | $71.99 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,450 | 94 | $0 (2024) |
| PFIZER INC. | $527.49 | 39 | $0 (2024) |
| UCB, Inc. | $482.58 | 21 | $0 (2020) |
| Janssen Biotech, Inc. | $377.93 | 18 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $315.04 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $274.23 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $245.91 | 17 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $198.02 | 13 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $167.57 | 10 | $0 (2022) |
| Braintree Laboratories, Inc. | $112.50 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $459.86 | 22 | ABBVIE INC. ($195.33) |
| 2023 | $489.86 | 27 | AbbVie Inc. ($194.01) |
| 2022 | $827.88 | 46 | ABBVIE INC. ($240.09) |
| 2021 | $1,316 | 92 | AbbVie Inc. ($535.99) |
| 2020 | $639.00 | 40 | AbbVie Inc. ($268.20) |
| 2019 | $655.40 | 40 | UCB, Inc. ($211.25) |
| 2018 | $453.46 | 27 | UCB, Inc. ($159.53) |
| 2017 | $294.07 | 19 | UCB, Inc. ($84.60) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/08/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $28.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Neuroscience | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Neuroscience | ||||||
| 04/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.06 | General |
| 03/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Immunology | ||||||
| 03/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 01/16/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: GI | ||||||
| 01/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology | ||||||
| 12/01/2023 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Medical Device | ||||||
| 11/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 704 | 791 | $270,931 | $80,792 |
| 2022 | 12 | 793 | 911 | $315,983 | $94,194 |
| 2021 | 15 | 899 | 1,037 | $342,094 | $104,068 |
| 2020 | 16 | 843 | 976 | $296,985 | $86,911 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 320 | $53,120 | $29,592 | 55.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 45 | 45 | $35,370 | $9,233 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 118 | 122 | $59,170 | $8,826 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 60 | 60 | $41,640 | $7,296 | 17.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $23,940 | $6,575 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 105 | $12,285 | $6,022 | 49.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 29 | 29 | $18,270 | $5,160 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,086 | $4,336 | 43.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $9,450 | $1,979 | 20.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 16 | $7,600 | $1,774 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 362 | $60,092 | $32,202 | 53.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 63 | 63 | $49,518 | $12,423 | 25.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 125 | 126 | $61,110 | $8,657 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $51,356 | $8,513 | 16.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 47 | 47 | $29,610 | $8,235 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 96 | $11,232 | $6,353 | 56.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $14,268 | $5,370 | 37.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $11,970 | $3,303 | 27.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,168 | $2,879 | 55.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $10,080 | $2,284 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $3,504 | $2,252 | 64.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 17 | 17 | $8,075 | $1,723 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 234 | 317 | $52,622 | $29,647 | 56.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 55 | 55 | $43,230 | $10,342 | 23.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 138 | 140 | $67,900 | $10,075 | 14.8% |
About Dr. Margaret Bailey, M.D
Dr. Margaret Bailey, M.D is a Specialist healthcare provider based in Camillus, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518946433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margaret Bailey, M.D has received a total of $5,136 in payments from pharmaceutical and medical device companies, with $459.86 received in 2024. These payments were reported across 313 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,064).
As a Medicare-enrolled provider, Bailey has provided services to 3,239 Medicare beneficiaries, totaling 3,715 services with total Medicare billing of $365,965. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Camillus, NY
- Active Since 01/10/2006
- Last Updated 11/29/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1518946433
Products in Payments
- HUMIRA (Biological) $729.72
- XELJANZ (Drug) $509.89
- Cimzia (Drug) $482.58
- STELARA (Biological) $377.93
- XIFAXAN (Drug) $259.70
- RINVOQ (Biological) $229.87
- ENTYVIO (Biological) $226.84
- SKYRIZI (Biological) $215.19
- LINZESS (Drug) $174.21
- CLENPIQ (Drug) $122.77
- ZEPOSIA (Drug) $100.73
- MAVYRET (Drug) $93.52
- Trulance (Drug) $86.91
- DUPIXENT (Biological) $84.94
- OCALIVA (Drug) $83.74
- Sucraid (Drug) $80.90
- Linzess (Drug) $76.60
- CREON (Drug) $65.60
- SUTAB (Drug) $62.68
- ZYMFENTRA (Biological) $51.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Camillus
Ovid Neulander, M.d, M.D
Specialist — Payments: $1,916
Dennis Resetarits, M.d, M.D
Specialist — Payments: $550.59
Dr. Marian Neulander, M.d, M.D
Specialist
Mrs. Stacey Cappon, Otr/L, OTR/L
Specialist
Hanna Brovka
Specialist
Mrs. Amy Dewitt
Specialist